Statement Of Income And Retained Earnings

Modalis Therapeutics Corporation - Filing #7272022

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,337,650,000 JPY
-1,491,563,000 JPY
-2,548,378,000 JPY
-2,370,666,000 JPY
Non-operating income
Non-operating income
64,583,000 JPY
77,808,000 JPY
163,913,000 JPY
39,843,000 JPY
Non-operating expenses
Non-operating expenses
30,032,000 JPY
26,174,000 JPY
16,551,000 JPY
20,966,000 JPY
Ordinary profit (loss)
-1,303,099,000 JPY
-1,439,929,000 JPY
-2,401,016,000 JPY
-2,351,788,000 JPY
Extraordinary losses
Extraordinary losses
13,829,000 JPY
188,000 JPY
317,000 JPY
38,818,000 JPY
Profit (loss) before income taxes
-1,316,929,000 JPY
-1,440,117,000 JPY
-2,401,334,000 JPY
-2,390,607,000 JPY
Income taxes - current
965,000 JPY
965,000 JPY
1,213,000 JPY
1,213,000 JPY
Profit (loss)
-1,441,083,000 JPY
-1,317,894,000 JPY
-1,441,083,000 JPY
-1,441,083,000 JPY
JPY
-1,441,083,000 JPY
-2,402,547,000 JPY
-2,402,547,000 JPY
-2,391,821,000 JPY
-2,402,547,000 JPY
-2,402,547,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.